In the therapy of the same B16F10 tumor model with incomplete resection, the results showed that CP-PD-1 platelet treatment could decrease Tregs in TME while vastly increasing the frequency of reinvigorated CD8+T cells, demonstrating directly blocking tumor relapse. Here, CD8A is linked to neoplasm.